Concepedia

Michael Boyce

MB

Statistics

Publications

34

Citations

6.8K

H-Index

25

Active since

1990

Affiliations

Duke University(Current)

Harvard University

Howard Hughes Medical Institute

University of California, Berkeley

The University of Texas Southwestern Medical Center

Michael Boyce is an author at Duke University specializing in life sciences, molecular biology, and glycosylation pathways.

ORCID

Publications per year

1990–2023

34

Publications

34

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

Alexei Degterev, Zhihong Huang, Michael Boyce et al. · Nature Chemical Biology · 2005 · 3K citations

, , +17

A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress

Michael Boyce, Kevin F. Bryant, Céline Jousse et al. · Science · 2005 · 1.4K citations

, , +15

Metabolic cross-talk allows labeling of O-linked β- <i>N</i> -acetylglucosamine-modified proteins via the <i>N</i> -acetylgalactosamine salvage pathway

Michael Boyce, Isaac S. Carrico, Anjali S. Ganguli et al. · Proceedings of the National Academy of Sciences · 2011 · 356 citations · Full text

, , +16

Selective Inhibition of Eukaryotic Translation Initiation Factor 2α Dephosphorylation Potentiates Fatty Acid-induced Endoplasmic Reticulum Stress and Causes Pancreatic β-Cell Dysfunction and Apoptosis

Miriam Cnop, Laurence Ladrière, Paul Hekerman et al. · Journal of Biological Chemistry · 2006 · 285 citations · Full text

, , +16

Bringing chemistry to life

Michael Boyce, Carolyn R. Bertozzi · Nature Methods · 2011 · 215 citations · Full text

, , +10

1–5 of 34